Stocktoria

Bodhi Tree Biotechnology Inc BDTB

OTC · stock · Services-Management Consulting Services · website · IPO 2025-09-03

Bodhi Tree Biotechnology Inc (BDTB) earns a Piotroski F-score of 0/9 (weak financial health). It does not currently pay a dividend. FY2025 revenue was $17,000 at a -880.4% net margin.

0/9
Piotroski F — financial health
Altman Z″ — distress risk
Dividend payout · no dividend
Net margin-880.4%

How it ranks in Services · percentile among 941 companies

Piotroski Fstronger than 0%
Net marginstronger than 6%
Return on equitystronger than 10%

Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 0/9 tests passed

Sector peers · similar-size Services companies

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
BDTBBodhi Tree Biotechnology Inc0/9
GFLTGenFlat Holdings, Inc.4/9
BLNCBalance Labs, Inc.2/9
YSGLYellowstone Group Ltd.5/91.03
PHCIPanamera Holdings Corp4/9
AUCATIF Holdings Ltd3/9
GRNQGreenpro Capital Corp.1/9

All Services companies →

FAQ

Is BDTB financially healthy?

Bodhi Tree Biotechnology Inc's Piotroski F-score is 0/9 (8–9 is excellent, 0–3 weak).

Does BDTB pay a dividend?

No, Bodhi Tree Biotechnology Inc does not currently pay a dividend.

How profitable is BDTB?

In FY2025, Bodhi Tree Biotechnology Inc had a net margin of -880.4% and a return on equity of -125.6%.

Source: SEC EDGAR filings · CIK 0002041531 · US · as of 2025-09-30. facts plus Stocktoria's own computed scores — not investment advice.